A panel at LSI USA ‘24 brought together industry leaders to discuss the rapidly evolving landscape of orthopedic surgery and the role of robotics in the growth of ambulatory surgery centers (ASCs). As the medtech market expands, these insights are invaluable for medical device investors and companies aiming to stay ahead of the curve. Here are six key points from the discussion that highlight the future direction of this dynamic field.

Open vs. Closed Robotic Systems

A significant debate at the conference was whether robotic systems should be implant-specific or open to multiple implants. Stuart Simpson, CEO of THINK Surgical, emphasized the importance of flexibility: "You shouldn’t have to make those trade-off decisions—you should be able to independently choose the right technology and the right implant for all your patients." This flexibility is particularly critical in ASCs, where surgeons often have varying preferences for implants. An implant-agnostic platform allows for better economic and clinical outcomes, catering to diverse needs within a single center.

Importance of Financial Efficiency in ASCs

Ambulatory surgery centers are designed to be financially efficient, which requires a strategic approach to partnerships and technology investments. Christopher Campbell of DePuy Synthes/Johnson & Johnson highlighted this point, noting, "ASCs are efficient financial institutions aimed at bringing patients in, giving them excellent service, and sending them out the door in the same day." For medtech companies to succeed in this market, aligning with the financial goals of ASCs while maintaining clinical efficacy is crucial. This balance ensures that ASCs can operate efficiently without compromising patient care.

Challenges of Robotics in Ambulatory Surgery Centers

Integrating surgical robotics into ASCs presents unique challenges due to these centers’ diverse nature and financial constraints. Clement Vidal of eCential Robotics explained, "ASCs cannot afford to have a single robot for each indication—they need a platform that supports multiple surgical indications across orthopedics." Developing versatile, cost-effective robotic platforms that can be used for various procedures is essential for broader adoption in ASCs. Such platforms can help meet the needs of different surgeons while maintaining financial viability.

Evolution of Business Models

Traditional business models, where companies offer free robots in exchange for implant purchases, are becoming less attractive. Stuart Simpson discussed the shift towards more transparent and flexible business models: "Customers are becoming fatigued by that. They realize that there’s no such thing as a free robot if you’re locked into buying implants at fixed prices for years." As the medtech market evolves, companies are moving towards models for which robots are paid independently. This approach allows for greater freedom in implant choices, fostering competition and innovation.

Role of Advanced Technologies

Advanced technologies like augmented reality (AR) and virtual reality (VR) can complement robotic systems but are not replacements. Clement Vidal stated, "Robots are more precise than navigation. AR and VR are essentially navigation tools, but robots offer superior precision for surgical procedures." The integration of these technologies can enhance surgical precision and outcomes, but robots will remain central to complex surgical interventions. This combination of technologies ensures that surgeons have the best tools available for various surgical challenges.

Training and Future Evolution

Training healthcare providers and evolving robotic technologies are vital for meeting the growing demands of ASCs. Christopher Prentice of LEM Surgical emphasized the importance of expanding revenue opportunities, including services and training: "We need to expand our view of revenue opportunities, including services and training, as ASCs run very tight ships." Continuous evolution and adaptation of robotic systems, along with comprehensive training programs, will ensure that ASCs can maintain high standards of care and efficiency. This focus on training and support helps integrate new technologies seamlessly into clinical practice.

Conclusion

The full recording of the panel can be found in LSI’s resource hub at the link below:

• ASCs: The Next Frontier of Robotics and Digital Medicine

The medtech market is witnessing significant shifts with the increasing integration of robotic systems in ambulatory surgery centers. By focusing on flexibility, financial efficiency, advanced technologies, and evolving business models, medtech companies and medical device investors can better navigate this complex landscape. These strategies enhance patient care and ensure sustainable growth and innovation in the industry. As the insights from the medtech conference demonstrate, staying ahead in this dynamic market requires a commitment to innovation and a keen understanding of the unique needs of ASCs.

To hear more insights like this, join hundreds of executives at LSI Europe ‘25 at the JW Marriott Grosvenor House London from September 7th to 11th, 2025.